Wim Terpstra

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Lorenzo Falchi, Marcel Nijland, Huiqiang Huang, Kim Linton et autres

us, nl, cn, gb, au, br, gr, at, es, il, fr, it, nz, hu, cz, ar, kr, jp, dk (code pays fourni par la source)

Long term follow-up and results of retreatement after obinutuzumab-venetoclax in first-line CLL patients with coexisting conditions

Mark‐David Levin, Sabina Kersting, Kazem Nasserinejad, Johan A. Dobber et autres

nl, us (code pays fourni par la source)

Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP

Marcel Nijland, Djamila E. Issa, Johanna A.A. Bult, Dries Deeren et autres

nl, be (code pays fourni par la source)

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial

Martine E D Chamuleau, F. Stenner, Dana Chiţu, Urban Novak et autres

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial

Martine E.D. Chamuleau, Frank Stenner, Dana Chiţu, Urban Novak et autres

nl, ch, be (code pays fourni par la source)

Analysis of complications and revisions after spine surgery in 270 multiple myeloma patients with spinal involvement

Hester Zijlstra, Robert‐Jan Pierik, Alexander M. Crawford, Daniel G. Tobert et autres

us, nl (code pays fourni par la source)

Neurological Outcomes and the Need for Retreatments Among Multiple Myeloma Patients With High-Grade Spinal Cord Compression: Radiotherapy vs Surgery

Hester Zijlstra, Alexander M. Crawford, Brendan M. Striano, Robert‐Jan Pierik et autres

us, nl (code pays fourni par la source)

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

Lina van der Straten, Claudia A.M. Stege, Sabina Kersting, Kazem Nasserinejad et autres

nl, us (code pays fourni par la source)

R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY DIAGNOSED HIGH‐RISK BURKITT LYMPHOMA: FINAL RESULTS OF A MULTI‐CENTER RANDOMIZED HOVON/SAKK TRIAL

Martine E.D. Chamuleau, Frank Stenner, Dana Chiţu, Urban Novak et autres

nl, ch, be (code pays fourni par la source)

The incidence of vertebral compression fractures and spinal instability in newly diagnosed multiple myeloma patients

Hester Zijlstra, Nienke Wolterbeek, Noa H. M. Ponds, Harry R. Koene et autres

nl (code pays fourni par la source)

R-CODOX-M/R-IVA Versus DA-EPOCH-R in Patients with Newly Diagnosed Burkitt Lymphoma. Final Results of A Multicenter Randomized HOVON/SAKK Trial

Martine E.D. Chamuleau, Frank Stenner, Dana Chiţu, Urban Novak et autres

nl, ch, us, be (code pays fourni par la source)

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial

Sabina Kersting, Julie Dubois, Kazem Nasserinejad, Johan A. Dobber et autres

nl, us, gb (code pays fourni par la source)